Luminescent, Oxygen‐Supplying, Hemoglobin‐Linked Conjugated Polymer Nanoparticles for Photodynamic Therapy. Issue 31 (27th June 2019)

• Record Type: Journal Article
• Authors: Jiang, Linye; Bai, Haotian; Liu, Libing; Lv, Fengting; Ren, Xueqin; Wang, Shu
• Is Part Of: Angewandte Chemie international edition. Volume 58:Issue 31(2019)
• Page Start: 10660
• Page End: 10665
• Publication Date: 2019-06-27
• Subjects: chemiluminescence -- conjugated polymer nanoparticles -- energy transfer -- photodynamic therapy -- self-supplied oxygen; Chemistry -- Periodicals; 540
• DOI: 10.1002/anie.201905884
• Languages: English
• ISSNs: 1433-7851

Abstract

Abstract: Photodynamic therapy (PDT) is a promising method for cancer treatment. Two parameters that influence the efficacy of PDT are the light source and oxygen supply. Herein, we prepared a system for PDT using hemoglobin (Hb)‐linked conjugated polymer nanoparticles (CPNs), which can luminesce and supply oxygen. Hb catalyzes the activation of luminol, the conjugated polymer poly[2‐methoxy‐5‐(2‐ethylhexyloxy)‐1, 4‐phenylenevinylene] (MEH–PPV) nanoparticles can absorb the chemiluminescence of luminol through chemiluminescence resonance energy transfer (CRET) and then sensitize the oxygen supplied by Hb to produce reactive oxygen species that kill cancer cells. This system could be used for the controlled release of an anticancer prodrug. The system does not need an external light source and circumvents the insufficient level molecular oxygen under hypoxia. This work provides a proof‐of‐concept to explore smart and multifunctional nanoplatforms for phototherapy. Abstract : A photodynamic therapy system has been developed using hemoglobin‐linked conjugated polymer nanoparticles that can luminesce and supply oxygen. This system does not require an external light source and circumvents the problem of low molecular oxygen levels found in hypoxic tissue. This system could also be used for the controlled release of an anticancer prodrug, combining PDT and chemotherapy.